Nilotinib (Tasigna) Therapy Post Allogeneic Stem Cell Transplantation (AlloSCT) for Advanced (>CP1) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
2012 ◽
Vol 18
(2)
◽
pp. S365
2020 ◽
Vol 26
(3)
◽
pp. S293-S294
2018 ◽
Vol 35
(2)
◽
pp. 240-247
◽